Theravance Bio Ord (TBPH)

While the concept of short-squeeze stocks has been all the rage throughout most of the pandemic-disruption cycle, we may have been doing this all wrong.…

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Jul 14, 2022

We're diving into all the latest stock market news with a breakdown of the biggest pre-market stock movers for Thursday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Sep 15, 2021

Good morning, investor! We're jumping back into the stock market as we take a look at the biggest pre-market stock movers for Wednesday.

7 Busted Biotech Stocks Due for a Rebound

By Chris Lau, InvestorPlace Contributor Sep 8, 2021

Buying biotech stocks while they're down is rewarding once they post positive clinical results, setting the stage for a big rally.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer Aug 24, 2021

Good morning, investor! We're getting ready for another busy day of trading with a dive into the biggest pre-market stock movers for Tuesday.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jun 25, 2021

We're back at it again with another look at the biggest pre-market stock movers for Friday as the perfect way to close out the week.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Jun 21, 2021

Welcome back and let's get ready to for another busy week of trading. Join us as we look at the biggest pre-market stock movers for Monday!

7 Biotech Stocks to Buy With Plenty of Power in the Pipeline

By Chris Lau, InvestorPlace Contributor Nov 12, 2019

With biotech stocks back in favor, investors may selectively pick only those with a deep drug pipeline ahead.

You Can Get Buy Signals From Short Selling

By Mark Putrino, CMT May 22, 2019

A high short interest in a stock could be a buy signal. That is becaise the short sellers will eventually need to buy it back.

Hottest Manufacturing Stocks Now – TTMI SHLM TPX FFIV

By Portfolio Grader Oct 27, 2016

The following stocks were moving the Manufacturing sector today.

Biggest Movers in Manufacturing Stocks Now – CERC KMG ASMB SKY

By Portfolio Grader Oct 14, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

Hottest Manufacturing Stocks Now – IPCI CCCL MWA VBLT

By Portfolio Grader Oct 12, 2016

The following stocks were the biggest movers and shakers in the Manufacturing sector today.

10 Biotech Stocks to Put on Your Radar This Quarter

By James Brumley, InvestorPlace Feature Writer Oct 3, 2016

Q4 is usually a winner for biotech stocks, but these stocks could deliver more than their fair share of wins during the coming three months.

Theravance Biopharma GAAP EPS of -$0.17 misses by $0.02, revenue of $17.6M beats by $0.03M (NASDAQ:TBPH)

From Seeking Alpha Feb 26, 2024

Theravance Biopharma reported Q4 financial results, with a miss on EPS but a beat on revenue.

Theravance, Mylan settle Yupelri patent dispute with Orbicular

From Seeking Alpha Jan 16, 2024

Theravance Biopharma (TBPH) and Viatris (VTRS) unit, Mylan settle patent dispute over generic Yupelri with Orbicular Pharmaceutical Technologies, Read more here.

Theravance stock drops as late-stage trial for Yupelri fails

From Seeking Alpha Jan 5, 2024

Theravance Biopharma (TBPH) stock drops 16% as its lung disorder therapy, Yupelri, fails to meet primary endpoint in Phase 4 trial. Read more here.

Theravance Biopharma signs cooperation agreement with Irenic Capital (NASDAQ:TBPH)

From Seeking Alpha Dec 21, 2023

Theravance Biopharma teams up with activist investor Irenic Capital Management as Jeremy Grant joins board.

Theravance, Mylan settle patent litigation over COPD drug Yupelri (TBPH)

From Seeking Alpha Oct 30, 2023

Theravance (TBPH) and Mylan (VTRS)have granted Teva (TEVA) a license to market a generic version of their drug Yupelri in the US, settling their patent dispute. Read more here.

Robert W. Baird Reaffirms Their Hold Rating on Theravance Biopharma (TBPH)

From TipRanks Nov 10, 2022

In a report released on November 7, Brian Skorney from Robert W. Baird maintained a Hold rating on Theravance Biopharma (TBPH – Research Report), with a price...

Theravance Bio Ord (TBPH)

TBPH Stock Earnings: Theravance Biopharma Beats EPS, Beats Revenue for Q1 2024

BTIG Research Predicts Over 118% Rally for These 3 Stocks

Short-Squeeze Showdown: 3 Stocks Ready to Crush the Skeptics

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Theravance Bio Ord (TBPH)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

TBPH Stock Predictions, Articles, and Theravance Bio Ord News

Subscriber Sign in